lobendazole (Compound)

Synonyms:Lobendazole, 6306-71-4, Ethyl 2-benzimidazolecarbamate, NSC-42044, ethyl (1H-benzo[d]imidazol-2-yl)carbamate, SK&F 24529, Ethyl 1H-benzimidazol-2-ylcarbamate, 2-Carboethoxyaminobenzimidazole, Ethyl 2-benzimidazolylcarbamate, N-(2'-Benzimidazolyl)-urethane, 2-Benzimidazolecarbamic acid, ethyl ester, ethyl N-(1H-benzimidazol-2-yl)carbamate, Ethyl N-(2-benzimidazolyl)carbamate, SKF 24529, Benzimidazol-2-ylcarbamate ethyl ester, N-(2-Benzimidazolyl)carbamic acid ethyl ester, CMF6Z78SWL, 2-((Ethoxycarbonyl)amino)benzimidazole, Carbamic acid, 1H-benzimidazol-2-yl-, ethyl ester, NSC42044, N-(1H-BENZIMIDAZOL-2-YL)CARBAMIC ACID ETHYL ESTER, ethyl 1H-benzo[d]imidazol-2-ylcarbamate, Ethyl(1H-benzo[d]imidazol-2-yl)carbamate, ethyl N-(1H-1,3-benzodiazol-2-yl)carbamate, Lobendazol, Lobendazolum, Lobendazole [USAN:INN], Lobendazol [INN-Spanish], Lobendazolum [INN-Latin], Ethyl benzimidazolecarbamate, 2-[(Ethoxycarbonyl)amino]benzimidazole, Ethyl 1H-benzimidazolylcarbamate, UNII-CMF6Z78SWL, NSC 42044, Benzimidazole carbamate d'ethyle [French], Benzimidazole carbamate d'ethyle, G 756, delta2,N-Benzimidazolinecarbamic acid, ethyl ester, CARBAMIC ACID, (2-BENZIMIDAZOLYL)-, ETHYL ESTER, CBDZ-M, Lobendazole, ethyl ester, ChemDivAM_000121, LOBENDAZOLE [INN], Lobendazole (USAN/INN), .DELTA.2, ethyl ester, ChemDiv1_000153, LOBENDAZOLE [USAN], (1H-Benzoimidazol-2-yl)-carbamic acid ethyl ester, MLS006011651, SCHEMBL205437, CHEMBL2105088, CHEBI:92287, HMS587G21, DTXSID70212390, HMS2093J17, Pharmakon1600-01505440, SKF24529, NSC759134, NSC764935, AKOS000538793, CCG-103228, NSC-759134, NSC-764935, SK&F-24529, NCGC00263896-03, SMR000069102, SBI-0206847.P001, G-756, D04754, EN300-265749, AB00275634_02, Carbamic acid, 1H-benzimidazol-2-yl-,ethyl ester, SR-05000002015, (R)-Piperidine-1,3-dicarboxylic acid1-benzylester, SR-05000002015-1, BRD-K15834839-001-01-5, Q27164045, F0348-2711

Pubchem:PUBCHEM:22752

Id:675295a3-34b7-5538-a2c6-4e35f6a79711

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View lobendazole's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for lobendazole.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with lobendazole.

Results found

Linked to

	Label	Description
	BRD-K15834839-001-02-3 Substance (Entity type)	A Substance
	lobendazole (e1182907-2646-45d7-8e55-da9f7f964919) Collection (Entity type)	Metadatata for lobendazole
	lobendazole in similarity relationship with Meloxicam Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	lobendazole negatively regulates LGALS3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	lobendazole negatively regulates CXCL8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	lobendazole positively regulates MAGEA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	lobendazole positively regulates SEMA3C Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	lobendazole positively regulates AUTS2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	lobendazole negatively regulates NQO2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	lobendazole positively regulates HMGN3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS